Gene-based therapies for neuromuscular disorders. [PDF]
Arq NeuropsiquiatrZanoteli E, França MC, Marques W.
europepmc +1 more source
Commentary: Urinary Neopterin, a New Marker of the Neuroinflammatory Status in Amyotrophic Lateral Sclerosis. [PDF]
Front Neurosci, 2021 Espíndola G, Scheffer DDL, Latini A.
europepmc +1 more source
Rehabilitation interventions targeting the activity and participation of patient with neuromuscular diseases: what do we know? A systematic review. [PDF]
Arq NeuropsiquiatrSilva SF +5 more
europepmc +1 more source
Congenital myasthenic syndrome in a cohort of patients with 'double' seronegative myasthenia gravis. [PDF]
Arq Neuropsiquiatr, 2022 Lorenzoni PJ +9 more
europepmc +1 more source
Is there a decline in speech and swallowing in Amyotrophic Lateral Sclerosis over ten years? [PDF]
CodasMendes RA +3 more
europepmc +1 more source
Profile of neurological disorders in a tertiary center of education in orthopedics. [PDF]
Arq Neuropsiquiatr, 2023 Vilaça CO, Souza F, Barbato KBG.
europepmc +1 more source
[Instability Prevention and Treatment in Total Hip Replacement]. [PDF]
Rev Bras Ortop (Sao Paulo)Rudelli BA +5 more
europepmc +1 more source
Self-perception of swallowing, vocal symptoms, and the possibility of dysphagia occurrence in patients under palliative care. [PDF]
CodasRodrigues SE +3 more
europepmc +1 more source
Model based on clinical characteristics to identify patients with neurogenic oropharyngeal dysphagia. [PDF]
Rev CuidSuárez-Escudero JC +4 more
europepmc +1 more source
[Evidence map on post-acute COVID-19 sequelae and rehabilitation: Update as of July 2022Mapa de evidencia sobre las secuelas y la rehabilitación tras la COVID-19 aguda: versión actualizada en julio del 2022]. [PDF]
Rev Panam Salud Publica, 2023 Ostolin TLVDP, Miranda RADR, Abdala CVM.
europepmc +1 more source